Statin use is associated with improved overall survival and progression-free survival in lung cancer
Statin use linked to better survival in lung cancer patients
This meta-analysis of 5,156 patients found that statin use was associated with significantly improved overall survival (HR = 0.76) and progr…
New data suggests that patients taking statins may live longer and stay cancer-free longer while undergoing specific lung cancer treatments.
High-dose statin preloading increases TIMI flow grade 3 and reduces all-cause mortality in STEMI
High dose statins may improve outcomes for heart attack patients
This meta-analysis of 1862 patients with STEMI undergoing primary PCI indicates that high-dose statin preloading is associated with improved…
A high dose of statins before a heart procedure may improve blood flow and lower death rates for patients with a heart attack.
Fibrosis-informed markers provide a decision architecture for statin allocation in intermediate-risk MASLD patients
New guidelines help doctors choose statins for liver disease patients
This guideline proposes a decision-making framework for statin therapy in the intermediate-risk stratum for patients with MASLD. It utilizes…
Doctors now have a clearer way to decide who needs statin treatment when liver health and heart risk overlap.
PCSK9 inhibitors provide consistent reductions in major adverse cardiovascular events for patients with diabetes mellitus
New drug options help manage heart risks in people with diabetes
This narrative review examines the role of PCSK9 inhibitors in managing lipid levels and cardiovascular outcomes in patients with diabetes m…
A new class of drugs shows promise for people with diabetes who cannot lower their cholesterol enough with standard treatments.
PCSK9 inhibitors significantly reduce LDL-C levels in patients with atherosclerotic cardiovascular disease
PCSK9 inhibitors lower LDL but not stroke risk
This meta-analysis of 63,328 patients evaluated the efficacy and cost-effectiveness of alirocumab, evolocumab, and inclisiran compared to st…
A large meta-analysis finds PCSK9 inhibitors cut LDL and heart attacks, but stroke risk was unchanged. Evolocumab may offer the best value.
PCSK9 inhibitors reduce LDL-C by 35.44% in children with heterozygous familial hypercholesterolaemia
PCSK9 inhibitors lower LDL cholesterol in children with high risk
This systematic review and meta-analysis of randomized controlled trials found that PCSK9 inhibitors as add-on therapy significantly reduced…
New data shows PCSK9 inhibitors significantly lower bad cholesterol in children who do not reach health goals on standard medications.
EPA and DHA supplementation significantly lowers inflammatory markers in coronary artery disease patients
Fish oil supplements may lower inflammation in heart disease patients
This secondary analysis of a randomized trial involved 240 patients with stable coronary artery disease on statin therapy. Supplementation w…
A study shows that taking specific fish oils can lower certain markers of inflammation in people with coronary artery disease.
Statin therapy reduces hepatocellular carcinoma risk and hepatic decompensation by 46% in chronic liver disease
Statin Therapy Linked to Lower Risks in Chronic Liver Disease
This umbrella review of systematic reviews analyzed data from 10,515,877 participants to evaluate statin effects on chronic liver disease. T…
A large-scale review suggests statin use may lower the risk of liver cancer and serious complications for people with chronic liver disease.
Shared molecular pathways and hub genes link endocrine disorders with periodontitis progression
Shared Molecular Pathways Link Endocrine Disorders and Periodontitis
This narrative review synthesizes the molecular mechanisms underlying the crosstalk between endocrine disorders and periodntis. It identifie…
New research identifies shared biological pathways that link endocrine disorders with gum disease, potentially changing how doctors treat bo…
General medical management improves medication adherence and lifestyle outcomes in older adults with type 2 diabetes
New management model improves medication use and health for seniors
This randomized controlled trial of 200 older adults with type 2 diabetes and atherosclerotic cardiovascular disease found that a general me…
A new personalized care plan helps older adults with diabetes and heart disease stay on their medications and improve their daily habits.
Statin use and EGFR-TKI efficacy in EGFR-mutant non-small cell lung cancer remains to be evaluated
Statins may boost lung cancer treatment, review planned
This protocol for a systematic review and meta-analysis aims to evaluate if statin exposure is associated with improved outcomes in patients…
A new review will examine if statins improve survival in EGFR-mutant lung cancer patients on targeted therapy.
Multi-target therapies may address combined hypertension and dyslipidemia pathophysiology
Multi-Target Therapies May Address Combined Hypertension and High Cholesterol
This systematic review synthesizes evidence on synergistic mechanisms of hypertension and dyslipidemia, highlighting the RAAS/PPAR axis, AMP…
Combining treatments like statins and RAAS inhibitors may offer a more precise way to manage both high blood pressure and cholesterol levels…
All statins Articles
- Statin use is associated with improved overall survival and progression-free survival in lung cancer
- High-dose statin preloading increases TIMI flow grade 3 and reduces all-cause mortality in STEMI
- Fibrosis-informed markers provide a decision architecture for statin allocation in intermediate-risk MASLD patients
- PCSK9 inhibitors provide consistent reductions in major adverse cardiovascular events for patients with diabetes mellitus
- PCSK9 inhibitors significantly reduce LDL-C levels in patients with atherosclerotic cardiovascular disease
- PCSK9 inhibitors reduce LDL-C by 35.44% in children with heterozygous familial hypercholesterolaemia
- EPA and DHA supplementation significantly lowers inflammatory markers in coronary artery disease patients
- Statin therapy reduces hepatocellular carcinoma risk and hepatic decompensation by 46% in chronic liver disease
- Shared molecular pathways and hub genes link endocrine disorders with periodontitis progression
- General medical management improves medication adherence and lifestyle outcomes in older adults with type 2 diabetes
- Statin use and EGFR-TKI efficacy in EGFR-mutant non-small cell lung cancer remains to be evaluated
- Multi-target therapies may address combined hypertension and dyslipidemia pathophysiology
- Research in coronary heart disease shows misalignment between investment and clinical guideline priorities
- Microcirculatory dysfunction during cardiac surgery remains heterogeneous and inconclusive in current clinical evidence
- Statins reduce recurrence risk 23% and mortality in 267,913 HR+ breast cancer patients with HR 0.77
- Favorable adiposity, statins, vitamin D, dried fruit linked to lower ovarian cancer risk in MR meta-analysis
- Narrative review suggests precision interventions for preeclampsia phenotypes
- Meta-analysis on Tongxinluo plus statins for carotid atherosclerosis
- Pre-admission statin use linked to better 30-day outcomes after aneurysmal SAH
- Nurse-led care coordination fails to improve medication adherence in high-need patients
- High LDL-C to HDL-C ratio linked to cardiovascular events in type 2 diabetes with retinopathy
- Diabetes Prevalence and Clinical Correlates in Hospitalized Heart Failure Patients in China
- PCSK9 inhibitor initiation associated with lower depression risk versus statins in hyperlipidemia
- Meta-analysis finds no significant association between statin use and ALS survival outcomes